Stocks · News reference

TD Cowen Maintains Buy on Medtronic, Raises Price Target to $110

Aug 28, 2026, 4:02 PMBenzinga Newsdesk

TD Cowen analyst Joshua Jennings maintains Medtronic (NYSE:MDT) with a Buy and raises the price target from $100 to $110.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 28, 2026, 10:03 AMAvi Kapoor
Medtronic Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Medtronic plc (NYSE: MDT) will release Q1 earnings on Sept. 1. Analysts predict $1.39 EPS and $9.54B revenue. Stock fell 2.2% to $89.97 on Aug. 27.
Read original at benzinga
MDT
BenzingaAug 27, 2026, 12:07 PMBenzinga Newsdesk
Needham Maintains Buy on Medtronic, Raises Price Target to $114
Needham analyst Mike Matson maintains Medtronic (NYSE:MDT) with a Buy and raises the price target from $101 to $114.
Read original at benzinga
MDT
Globenewswire IncAug 26, 2026, 11:57 AMResearchandmarkets.Com
Atrial Fibrillation Treatment Devices Market Trends and Forecast, 2035 | Includes Profiles of Abbott, AtriCure, Boston Scientific, Johnson & Johnson, and Medtronic
The global atrial fibrillation treatment devices market is expected to grow at a 13.1% CAGR from $9.6 billion in 2026 to $29 billion by 2035, driven by aging populations, rising AF prevalence affecting 50-60 million people worldwide, and increasing adoption of advanced ablation and left atrial appendage closure technologies. Pulsed field ablation is forecast to generate over 60% of market revenue by 2035, while North America will retain approximately 50% of global market share. Asia-Pacific is expected to register the fastest regional growth.
Read original at globenewswire-inc
ABT BSX ATRC MDT JNJ